Abstract
Objective
To compare short-term results of total mesorectal excision (TME) for mid and low rectal cancer, achieved by transanal (TaTME), laparoscopic (LaTME), and open (OpTME) approaches.
Background
The impact of TaTME on the surgical treatment of mid and low rectal cancer has yet to be clarified.
Methods
This is a case-matched study, based on data from a prospectively maintained database of patients who underwent TaTME from May 2015 to March 2017, and a retrospective chart review of patients who underwent LaTME and OpTME in the previous period. Each patient in the TaTME group was matched to one LaTME and one OpTME based on sex, BMI, tumor status, and the height of the tumor from the anal verge. Primary end-points were rates of positive circumferential resection margin (CRM), distal resection margin, and the macroscopic quality of the surgical specimen. Composite of these outcomes was compared as an indication for successful surgery. Secondary end-points included intraoperative data and postoperative course and complications.
Results
Three hundred patients were included (TaTME = 100, LaTME = 100, OpTME = 100). The three groups were comparable in the baseline characteristics. TaTME resulted in lower rates of incomplete TME specimens than LaTME, but not OpTME (P = 0.016, P = 0.750, respectively). The rates of CRM involvement, mean CRM distance, and the percentages of successful surgery were comparable among the three groups (P = 0.368). The conversion to open surgery occurred only in the LaTME group. TaTME resulted in shorter operation time and less blood loss than the other two groups (P < 0.001 and P < 0.001). Hospital stay was shorter in the TaTME group (P = 0.002); complication rate and mortality were comparable among the groups.
Conclusions
TaTME had, in our hands, some obvious benefits over other approaches. The pathological results were not significantly superior to LaTME and OpTME. The procedure is however feasible and safe. Further studies are needed to evaluate the long-term oncological and quality of life outcomes.
Similar content being viewed by others
References
Heald RJ (1979) A new approach to rectal cancer. Br J Hosp Med 22:277–281
Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg 69:613–616
Heald RJ, Moran BJ, Ryall RD et al (1998) Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg 133:894–899
Bonjer HJ, Deijen CL, Abis GA et al (2015) A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med 372:1324–1332
Fleshman J, Branda M, Sargent DJ et al (2015) Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 314:1346–1355
Stevenson AR, Solomon MJ, Lumley JW et al (2015) Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 314:1356–1363
Jeong SY, Park JW, Nam BH et al (2014) Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol 15:767–774
Rickles AS, Dietz DW, Chang GJ et al (2015) High rate of positive circumferential resection margins following rectal cancer surgery: a call to action. Ann Surg 262:891–898
Guillou PJ, Quirke P, Thorpe H et al (2005) Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 365:1718–1726
Heald RJ (2013) A new solution to some old problems: transanal TME. Tech Coloproctol 17:257–258
D’Hoore A, Wolthuis AM, Sands DR, Wexner S (2016) Transanal total mesorectal excision: the work is progressing well. Dis Colon Rectum 59:247–250
Simillis C, Hompes R, Penna M et al (2016) A systematic review of transanal total mesorectal excision: is this the future of rectal cancer surgery? Colorectal Dis 18:19–36
Perdawood SK, Al Khefagie GA (2016) Transanal vs laparoscopic total mesorectal excision for rectal cancer: initial experience from Denmark. Colorectal Dis 18:51–58
Bulow S, Harling H, Iversen LH, Ladelund S (2010) Improved survival after rectal cancer in Denmark. Colorectal Dis 12:e37-42
Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70:41–55
DCCG (2013) Recommendations of the Danish Colorectal Cancer Group: neoadjuvant treatment of advanced resectable rectal cancer. http://dccg.dk/retningslinjer/20140418/2014_NeoAdjRectum.pdf. Accessed April 2017
Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2:996–999
Quirke P, Steele R, Monson J et al (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373(9666):821–828
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Ng SS, Lee JF, Yiu RY et al (2014) Laparoscopic-assisted versus open total mesorectal excision with anal sphincter preservation for mid and low rectal cancer: a prospective, randomized trial. Surg Endosc 28:297–306
Bulow S, Christensen IJ, Iversen LH, Harling H (2011) Intra-operative perforation is an important predictor of local recurrence and impaired survival after abdominoperineal resection for rectal cancer. Colorectal Dis 13:1256–1264
Arteaga Gonzalez I, Diaz Luis H, Martin Malagon A et al (2006) A comparative clinical study of short-term results of laparoscopic surgery for rectal cancer during the learning curve. Int J Colorectal Dis 21:590–595
Braga M, Frasson M, Vignali A et al (2007) Laparoscopic resection in rectal cancer patients: outcome and cost-benefit analysis. Dis Colon Rectum 50:464–471
Chen CC, Lai YL, Jiang JK et al (2015) Transanal total mesorectal excision versus laparoscopic surgery for rectal cancer receiving neoadjuvant chemoradiation: a matched case-control study. Ann Surg Oncol. doi:10.1245/s10434-015-4997-y
Fernandez-Hevia M, Delgado S, Castells A et al (2015) Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery. Ann Surg 261:221–227
Rasulov AO, Mamedli ZZ, Gordeyev SS et al (2016) Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer. Tech Coloproctol. doi:10.1007/s10151-015-1421-3
Velthuis S, Nieuwenhuis DH, Ruijter TE et al (2014) Transanal versus traditional laparoscopic total mesorectal excision for rectal carcinoma. Surg Endosc 28:3494–3499
Deijen CL, Tsai A, Koedam TW et al (2016) Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review. Tech Coloproctol 20:811–824
Rouanet P, Mourregot A, Azar CC et al (2013) Transanal endoscopic proctectomy: an innovative procedure for difficult resection of rectal tumors in men with narrow pelvis. Dis Colon Rectum 56:408–415
Bülow S CI, Iversen LH et al (2011) Intra-operative perforation is an important predictor of local recurrence and impaired survival after abdominoperineal resection for rectal cancer. In Colorectal Dis 13(11):1256–1264
DCCG (2015) http://dccg.dk/pdf/Aarsrapport_2015.pdf; 26
Buunen M, Bonjer HJ, Hop WC et al (2009) COLOR II. A randomized clinical trial comparing laparoscopic and open surgery for rectal cancer. Dan Med Bull 56:89–91
Staderini F, Foppa C, Minuzzo A et al (2016) Robotic rectal surgery: state of the art. World J Gastrointest Oncol 8:757–771
Speicher PJ, Englum BR, Ganapathi AM et al (2015) Robotic low anterior resection for rectal cancer: a national perspective on short-term oncologic outcomes. Ann Surg 262:1040–1045
Collinson FJ, Jayne DG, Pigazzi A et al (2012) An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer. Int J Colorectal Dis 27:233–241
Penna M, Hompes R, Arnold S et al (2016) Transanal total mesorectal excision: international registry results of the first 720 cases. Ann Surg. doi:10.1097/SLA.0000000000001948
Xu W, Xu Z, Cheng H et al (2016) Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: a meta-analysis. Eur J Surg Oncol 42:1841–1850
Deijen CL, Velthuis S, Tsai A et al (2015) COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc. doi:10.1007/s00464-015-4615-x
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Drs. Sharaf Karim Perdawood, Benjamin Sejr Thinggaard, and Maya Xania Bjoern have no conflicts of interest or financial ties to disclose.
Rights and permissions
About this article
Cite this article
Perdawood, S.K., Thinggaard, B.S. & Bjoern, M.X. Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term outcomes with laparoscopic and open surgeries. Surg Endosc 32, 2312–2321 (2018). https://doi.org/10.1007/s00464-017-5926-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-017-5926-x